Therapy of neurodegenerative diseases using neurotrophic factors: Cell biological perspective

Expert Review of Neurotherapeutics

Volumn 2, Issue 3, 2002, Pages 417-426

  Brodski, Claude ^a   Vogt Weisenhorn, Daniela M ^a   Dechant, Georg ^a  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

Author keywords

ALS; Alzheimer's disease; BDNF; CNTF; GDNF; Neurodegeneration; Neurotrophin; NGF; Parkinson's disease; Ret; Trk

Indexed keywords

NEUROTROPHIC FACTOR;

CELL DEATH; CELL FUNCTION; CELL TYPE; CYTOLOGY; DEGENERATIVE DISEASE; DRUG MECHANISM; HUMAN; NEUROPROTECTION; REVIEW; SYNAPTIC TRANSMISSION;

EID: 0036285425     PISSN: 14737175     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737175.2.3.417     Document Type: Review

References (79)

1. How do neurons die in neurodegenerative diseases?
2. Neurotrophins: Key regulators of cell fate and cell shape in the vertebrate nervous system
3. The GDNF family ligands and receptors - Implications for neural development
4. The neurotrophins and neuropoietic cytokines: Two families of growth factors acting on neural and hematopoietic cells
5. The role of neuronal growth factors in neurodegenerative disorders of the human brain
6. Apoptosis, neurotrophic factors and neurodegeneration
7. Development of neurotrophic factor therapy for Alzheimer's disease
8. Neurotrophic factors for experimental treatment of motoneuron disease
9. Treatment of Degenerative Disorders of the Nervous System: From Helpless Descriptive Categorization to Rational Therapeutic Approaches
10. Neurotrophin regulation of the developing nervous system: Analyses of knockout mice
11. Viktor Hamburger and Rita Levi-Montalcini: The path to the discovery of nerve growth factor
12. Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons
13. Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo
14. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease
15. Nerve growth factor affects 11C-nicotine binding, blood flow, EEG and verbal episodic memory in an Alzheimer patient (case report)
16. Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease
17. A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III)
18. A double-blind placebo-controlled clinical trial of sc. recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis
19. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis
20. Cedarbaum JM. Intrathecal ciliary neurotrophic factor delivery for treatment of amyotrophic lateral sclerosis (phase I trial)
21. A Phase I/ II trial of recombinant methionyl human brain derived neurotrophic factor administered by it. Infusion to patients with amyotrophic lateral sclerosis
22. Distribution and retrograde transport of trophic factors in the central nervous system: Functional implications for the treatment of neurodegenerative diseases
23. Differential distribution of exogenous BDNF, NGF and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptors
24. Downregulation of the neurotrophin receptor TrkB following ligand binding. Evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB
25. Nerve growth factor and glial cell line-derived neurotrophic factor restore the cholinergic neuronal phenotype in organotypic brain slices of the basal nucleus of Meynert
26. Developmental changes in NT 3 signalling via TrkA and TrkB in embryonic neurons
27. Multiple effects of artemin on sympathetic neuron generation, survival and growth
28. NGF Utilizes c-Ret via a Novel GFL-Independent, Inter-RTK Signaling Mechanism to Maintain the Trophic Status of Mature Sympathetic Neurons
29. Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells
30. CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex
31. Development of sensory neurons in the absence of NGF/TrkA signaling in vivo
32. Cortical degeneration in the absence of neurotrophin signaling: Dendritic retraction and neuronal loss after removal of the receptor TrkB
33. Effects of brain-derived neurotrophic factor on optic axon branching and remodelling in vivo
34. Cellular and molecular mechanisms of dendrite growth
35. Truncated and-full-length TrkB receptors regulate distinct modes of dendritic growth
36. Nontropic actions of neurotrophins: Subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation
37. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities
38. BDNF regulates eating behavior and locomotor activity in mice
39. BDNF controls dopamine D 3 receptor expression and triggers behavioural sensitization
40. Neurotrophin- 3 promotes the cholinergic differentiation of sympathetic neurons
41. Neurotrophins and activity-dependent plasticity
42. Anterograde transport of neurotrophins and axodendritic transfer in the developing visual system
43. Activity-dependent transfer of brain-derived neurotrophic factor to postsynaptic neurons
44. Neurotrophin-evoked rapid excitation through TrkB receptors
45. Synapsins as mediators of BDNF-enhanced neurotransmitter release
46. Impairments in high-frequency transmission, synaptic vesicle docking and synaptic protein distribution in the hippocampus of BDNF knockout mice
47. Visualizing synapse formation in arborizing optic axons in vivo: Dynamics and modulation by BDNE
48. Dendritic spine changes associated with hippocampal long-term synaptic plasticity
49. Destabilization of cortical dendrites and spines by BDNF
50. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor
51. Potential role for TrkB receptors in hippocampus-mediated learning
52. The role of brain-derived neurotrophic factor receptors in the mature hippocampus: Modulation of long-term potentiation through a presynaptic mechanism involving TrkB
53. A caged Ab reveals an immediate/instructive effect of BDNF during hippocampal synaptic potentiation
54. Learning deficit in BDNF mutant mice
55. Correlation between hippocampal BDNF mRNA expression and memory performance in senescent rats
56. Amelioration of cholinergic neurone atrophy and spatial memory impairment in aged rats by nerve growth factor
57. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease
58. Transgenic mice expressing the intracellular domain of the p75 neurotrophin receptor undergo neuronal apoptosis
59. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75
60. Neurotrophins induce death of hippocampal neurons via the p75 receptor
61. Genetic evidence for cell death mediated by nerve growth factor and the neurotrophin receptor p75 in the developing mouse retina and spinal cord
62. NGFR and cholinergic neurons in the developing forebrain: A re-examination
63. Complete ablation of the neurotrophin receptor p75NTR causes defects both in the nervous and the vascular system
64. The complete deletion of the neurotrophin receptor p75NTR leads to longlasting increases in the number of basal forebrain cholinergic neurons
65. Regulation of cell survival by secreted proneurotrophins
66. Evolving better brains: A need for neurotrophins?
67. Intraparenchymal NGF infusions rescue degenerating cholinergic neurons
68. Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy
69. Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTE
70. Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expression
71. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
72. Receptors in neurodegenerative diseases
73. Pegylated brain-derived neurotrophic factor shows improved distribution into the spinal cord and stimulates locomotor activity and morphological changes after injury
74. Development of pharmacological agents for targeting neurotrophins and their receptors
75. Gene therapy of murine motor neurone disease using adenoviral vectors for neurotrophic factors
76. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration
77. Changes in cytokines and neurotrophins in Parkinson's disease
78. Growth factors regulate the survival and fate of cells derived from human neurospheres
79. Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus and hypothalamus